Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Proc Natl Acad Sci U S A ; 121(27): e2317077121, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38913899

ABSTRACT

We show that the Landsat and Sentinel-2 satellites can detect NO2 plumes from large point sources at 10 to 60 m pixel resolution in their blue and ultrablue bands. We use the resulting NO2 plume imagery to quantify nitrogen oxides (NOx) emission rates for several power plants in Saudi Arabia and the United States, including a 13-y analysis of 132 Landsat plumes from Riyadh power plant 9 from 2009 through 2021. NO2 in the plumes initially increases with distance from the source, likely reflecting recovery from ozone titration. The fine pixel resolutions of Landsat and Sentinel-2 enable separation of individual point sources and stacks, including in urban background, and the long records enable examination of multidecadal emission trends. Our inferred NOx emission rates are consistent with previous estimates to within a precision of about 30%. Sources down to ~500 kg h-1 can be detected over bright, quasi-homogeneous surfaces. The 2009 to 2021 data for Riyadh power plant 9 show a strong summer peak in emissions, consistent with increased power demand for air conditioning, and a marginal slow decrease following the introduction of Saudi Arabia's Ambient Air Standard 2012.

2.
Proc Natl Acad Sci U S A ; 121(12): e2314600121, 2024 Mar 19.
Article in English | MEDLINE | ID: mdl-38470920

ABSTRACT

Global atmospheric methane concentrations rose by 10 to 15 ppb/y in the 1980s before abruptly slowing to 2 to 8 ppb/y in the early 1990s. This period in the 1990s is known as the "methane slowdown" and has been attributed in part to the collapse of the former Soviet Union (USSR) in December 1991, which may have decreased the methane emissions from oil and gas operations. Here, we develop a methane plume detection system based on probabilistic deep learning and human-labeled training data. We use this method to detect methane plumes from Landsat 5 satellite observations over Turkmenistan from 1986 to 2011. We focus on Turkmenistan because economic data suggest it could account for half of the decline in oil and gas emissions from the former USSR. We find an increase in both the frequency of methane plume detections and the magnitude of methane emissions following the collapse of the USSR. We estimate a national loss rate from oil and gas infrastructure in Turkmenistan of more than 10% at times, which suggests the socioeconomic turmoil led to a lack of oversight and widespread infrastructure failure in the oil and gas sector. Our finding of increased oil and gas methane emissions from Turkmenistan following the USSR's collapse casts doubt on the long-standing hypothesis regarding the methane slowdown, begging the question: "what drove the 1992 methane slowdown?"

3.
Proc Natl Acad Sci U S A ; 120(52): e2310797120, 2023 Dec 26.
Article in English | MEDLINE | ID: mdl-38113260

ABSTRACT

We demonstrate geostationary satellite monitoring of large transient methane point sources with the US Geostationary Operational Environmental Satellites (GOES). GOES provides continuous 5- to 10-min coverage of the Americas at 1 to 2 km nadir pixel resolution in two shortwave infrared spectral bands from which large methane plumes can be retrieved. We track the full evolution of an extreme methane release from the El Encino-La Laguna natural gas pipeline in Durango, Mexico on 12 May 2019. The release lasted 3 h at a variable rate of 260 to 550 metric tons of methane per hour and totaled 1,130 to 1,380 metric tons. We report several other detections of transient point sources from oil/gas infrastructure, from which we infer a detection limit of 10 to 100 t h-1. Our results show that extreme releases of methane can last less than an hour, as from deliberate venting, and would thus be difficult to identify and quantify with low-Earth orbit satellites.

4.
Front Public Health ; 11: 1265323, 2023.
Article in English | MEDLINE | ID: mdl-37942255

ABSTRACT

Introduction: Even using well-established technology assessment processes, the basis of the decisions on drug price and reimbursement are sometimes perceived as poorly informed and sometimes may be seen as disconnected from value. The literature remains inconclusive about how Health Technology Assessment Bodies (HTAb) should report the determinants of their decisions. This study evaluates the relationship between oncology and hematology drug list prices and structured value parameters at the time of reimbursement decision in Spain. Methods: The study includes all new onco-hematological products (22), with a first indication authorized between January 2017 and December 2019 in Spain and pricing decisions published up until October 2022. For each product, 56 contextual and non-contextual indicators reflecting the structured multiple criteria decision analysis (MCDA) - Evidence-based Decision-Making (EVIDEM) framework were measured. The relationship between prices and the MCDA-EVIDEM framework was explored using univariate statistical analyses. Results: Higher prices were observed when the standard of care included for combinations, if there were references to long-lasting responses, for fixed-duration treatment compared to treatment until progression and treatment with lower frequencies of administration; lower prices were observed for oral administration compared to other routes of administration. Statistically significant associations were observed between prices and the median duration of treatment, the impact on patient autonomy, the ease of use of the drug, and the recommendations of experts. Discussion: The study suggests that indicators related to the type of standard of care, references to long-lasting responders, the convenience of the use of the drug, and the impact of treatment on patient autonomy, as well as contextual indicators such as the existence of previous clinical consensus, are factors in setting oncology drug prices in Spain. The implementation of MCDA-EVIDEM methodologies may be useful to capture the influence on pricing decisions of additional factors not included in legislation or consolidated assessment frameworks such as the European Network for Health Technology Assessment (EunetHTA) core model. It may be opportune to consider this in the upcoming revision of the Spanish regulation for health technology assessments and pricing and reimbursement procedures.


Subject(s)
Pharmaceutical Preparations , Humans , Spain , Costs and Cost Analysis , Consensus
5.
Proc Natl Acad Sci U S A ; 120(17): e2217900120, 2023 Apr 25.
Article in English | MEDLINE | ID: mdl-37068241

ABSTRACT

The United States is the world's largest oil/gas methane emitter according to current national reports. Reducing these emissions is a top priority in the US government's climate action plan. Here, we use a 2010 to 2019 high-resolution inversion of surface and satellite observations of atmospheric methane to quantify emission trends for individual oil/gas production regions in North America and relate them to production and infrastructure. We estimate a mean US oil/gas methane emission of 14.8 (12.4 to 16.5) Tg a-1 for 2010 to 2019, 70% higher than reported by the US Environmental Protection Agency. While emissions in Canada and Mexico decreased over the period, US emissions increased from 2010 to 2014, decreased until 2017, and rose again afterward. Increases were driven by the largest production regions (Permian, Anadarko, Marcellus), while emissions in the smaller production regions generally decreased. Much of the year-to-year emission variability can be explained by oil/gas production rates, active well counts, and new wells drilled, with the 2014 to 2017 decrease driven by reduction in new wells and the 2017 to 2019 surge driven by upswing of production. We find a steady decrease in the oil/gas methane intensity (emission per unit methane gas production) for almost all major US production regions. The mean US methane intensity decreased from 3.7% in 2010 to 2.5% in 2019. If the methane intensity for the oil/gas supply chain continues to decrease at this pace, we may expect a 32% decrease in US oil/gas emissions by 2030 despite projected increases in production.

6.
Sci Adv ; 8(32): eabn9683, 2022 Aug 12.
Article in English | MEDLINE | ID: mdl-35947659

ABSTRACT

As atmospheric methane concentrations increase at record pace, it is critical to identify individual emission sources with high potential for mitigation. Here, we leverage the synergy between satellite instruments with different spatiotemporal coverage and resolution to detect and quantify emissions from individual landfills. We use the global surveying Tropospheric Monitoring Instrument (TROPOMI) to identify large emission hot spots and then zoom in with high-resolution target-mode observations from the GHGSat instrument suite to identify the responsible facilities and characterize their emissions. Using this approach, we detect and analyze strongly emitting landfills (3 to 29 t hour-1) in Buenos Aires, Delhi, Lahore, and Mumbai. Using TROPOMI data in an inversion, we find that city-level emissions are 1.4 to 2.6 times larger than reported in commonly used emission inventories and that the landfills contribute 6 to 50% of those emissions. Our work demonstrates how complementary satellites enable global detection, identification, and monitoring of methane superemitters at the facility level.

7.
Sci Adv ; 7(27)2021 Jun.
Article in English | MEDLINE | ID: mdl-34193415

ABSTRACT

Industrial emissions play a major role in the global methane budget. The Permian basin is thought to be responsible for almost half of the methane emissions from all U.S. oil- and gas-producing regions, but little is known about individual contributors, a prerequisite for mitigation. We use a new class of satellite measurements acquired during several days in 2019 and 2020 to perform the first regional-scale and high-resolution survey of methane sources in the Permian. We find an unexpectedly large number of extreme point sources (37 plumes with emission rates >500 kg hour-1), which account for a range between 31 and 53% of the estimated emissions in the sampled area. Our analysis reveals that new facilities are major emitters in the area, often due to inefficient flaring operations (20% of detections). These results put current practices into question and are relevant to guide emission reduction efforts.

8.
Environ Sci Technol ; 54(16): 10246-10253, 2020 08 18.
Article in English | MEDLINE | ID: mdl-32672947

ABSTRACT

Satellite observations of atmospheric methane plumes offer a means for global mapping of methane point sources. Here we use the GHGSat-D satellite instrument with 50 m effective spatial resolution and 9-18% single-pass column precision to quantify mean source rates for three coal mine vents (San Juan, United States; Appin, Australia; and Bulianta, China) over a two-year period (2016-2018). This involves averaging wind-rotated observations from 14 to 24 overpasses to achieve satisfactory signal-to-noise. Our wind rotation method optimizes the wind direction information for individual plumes to account for error in meteorological databases. We derive source rates from the time-averaged plumes using integrated mass enhancement (IME) and cross-sectional flux (CSF) methods calibrated with large eddy simulations. We find time-averaged source rates ranging from 2320 to 5850 kg h-1 for the three coal mine vents, with 40-45% precision (1σ), and generally consistent with previous estimates. The IME and CSF methods agree within 15%. Our results demonstrate the potential of space-based monitoring for annual reporting of methane emissions from point sources and suggest that future satellite instruments with similar pixel resolution but better precision should be able to constrain a wide range of point sources.


Subject(s)
Air Pollutants , Methane , Air Pollutants/analysis , Australia , China , Coal , Cross-Sectional Studies , Environmental Monitoring , Methane/analysis
9.
Sci Adv ; 6(17): eaaz5120, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32494644

ABSTRACT

Using new satellite observations and atmospheric inverse modeling, we report methane emissions from the Permian Basin, which is among the world's most prolific oil-producing regions and accounts for >30% of total U.S. oil production. Based on satellite measurements from May 2018 to March 2019, Permian methane emissions from oil and natural gas production are estimated to be 2.7 ± 0.5 Tg a-1, representing the largest methane flux ever reported from a U.S. oil/gas-producing region and are more than two times higher than bottom-up inventory-based estimates. This magnitude of emissions is 3.7% of the gross gas extracted in the Permian, i.e., ~60% higher than the national average leakage rate. The high methane leakage rate is likely contributed by extensive venting and flaring, resulting from insufficient infrastructure to process and transport natural gas. This work demonstrates a high-resolution satellite data-based atmospheric inversion framework, providing a robust top-down analytical tool for quantifying and evaluating subregional methane emissions.

10.
Case Rep Psychiatry ; 2019: 9694765, 2019.
Article in English | MEDLINE | ID: mdl-31139486

ABSTRACT

The following case describes the utilization of bitemporal ECT as a treatment of last resort in a 47-year-old woman with profoundly treatment-resistant behavioral disturbance poststroke. The use of ECT led to improvement in symptoms sufficient for discharge from an inpatient psychiatric unit to the nursing home. Neuropsychiatric sequelae of stroke include poststroke depression, anxiety, mania, psychosis, apathy, pathological laughter and crying, catastrophic reaction, and mild and major vascular neurocognitive disorders. Behavioral disturbance is common and may pose diagnostic and therapeutic difficulty in the poststroke patient. In most cases, first-line treatment includes pharmacologic intervention tailored to the most likely underlying syndrome. Frequent use of sedating medications is a more drastic option when behaviors prove recalcitrant to first-line approaches and markedly affect quality of life and patient safety. ECT is generally safe, is well tolerated, and may be effective in improving symptoms in treatment-resistant behavioral disturbance secondary to stroke with major neurocognitive impairment, as suggested in this case.

11.
Curr Psychiatry Rep ; 17(7): 53, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25980510

ABSTRACT

Anxiety disorders are frequently encountered in the elderly, but they are largely undetected and untreated. Epidemiological studies indicate a prevalence ranging from 1.2 to 15 %. With the exception of generalized anxiety disorder and agoraphobia, which can often start in late life, most anxiety disorders in older patients are chronic and have their onset earlier in life. Anxiety disorders are an often unrecognized cause of distress, disability, and mortality risk in older adults, and they have been associated with cardiovascular disease, stroke, and cognitive decline. The mechanisms of anxiety in older adults differ from that in younger adults due to age-related neuropathology, as well as the loss and isolation so prominent in late life. Our review intends to provide a comprehensive summary of the most recent research done in the field of anxiety disorders in the elderly. Recent findings in clinical research, neuroimaging, neuroendocrinology, and neuropsychology are covered. An update on treatment options is discussed, including pharmacological and non-pharmacological alternatives.


Subject(s)
Anti-Anxiety Agents/therapeutic use , Anxiety Disorders , Brain/pathology , Brain/physiopathology , Cognition Disorders/complications , Cognition Disorders/etiology , Cognitive Behavioral Therapy , Acceptance and Commitment Therapy , Aged , Anxiety/diagnosis , Anxiety/therapy , Anxiety Disorders/complications , Anxiety Disorders/diagnosis , Anxiety Disorders/epidemiology , Anxiety Disorders/etiology , Anxiety Disorders/pathology , Anxiety Disorders/physiopathology , Anxiety Disorders/psychology , Anxiety Disorders/therapy , Cardiovascular Diseases/complications , Cardiovascular Diseases/etiology , Cognitive Behavioral Therapy/methods , Diagnosis, Differential , Evidence-Based Medicine , Humans , Mindfulness , Nerve Net/pathology , Nerve Net/physiopathology , Neuroimaging , Prevalence , Randomized Controlled Trials as Topic , Selective Serotonin Reuptake Inhibitors/therapeutic use , Social Isolation/psychology , Stress, Psychological/complications , Stress, Psychological/etiology , Treatment Outcome
12.
Int J Geriatr Psychiatry ; 30(2): 192-200, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24816477

ABSTRACT

OBJECTIVE: This study aims to determine the clinical utility of visual ratings and volumetric measurements of medial temporal atrophy among subjects from the Alzheimer's Disease Neurorimaging Initiative (ADNI) cohort. METHODS: A sample of 189 subjects from the ADNI, Phase 1 (ADNI-1), was chosen as follows: 49 cognitively normal (CN), 89 with mild cognitive impairment (MCI), and 50 with Alzheimer's disease (AD). Structural MRI images were downloaded from the ADNI website, and a visual rating system (VRS) was used to obtain semi-quantitative ratings of the hippocampus (HPC) and entorhinal cortex (ERC). VRS ratings and FreeSurfer measures of the HPC and ERC were used to predict (i) baseline diagnosis and (ii) progression to AD among subjects with MCI at baseline. RESULTS: VRS and FreeSurfer measures of ERC were equivalent in classifying subjects at baseline, but FreeSurfer measures of HPC were superior to VRS measures for classifying CN versus MCI subjects. VRS and FreeSurfer measures of both HPC and ERC were significant predictors of progression from MCI to AD. However, VRS ratings of ERC were superior to other MRI measures. MCI subjects with minimal ERC atrophy by VRS had a threefold lower progression rate to AD at 3.2 years compared with those with mild, moderate, or severe atrophy (23% vs 63%, 69%, and 87%, respectively). CONCLUSIONS: Visual ratings of HPC and ERC provide useful information to a physician in a clinical setting. Visual ratings of ERC may be especially useful in following patients with MCI.


Subject(s)
Alzheimer Disease/diagnosis , Cognitive Dysfunction/diagnosis , Entorhinal Cortex/pathology , Hippocampus/pathology , Magnetic Resonance Imaging , Aged , Aged, 80 and over , Alzheimer Disease/complications , Atrophy/pathology , Case-Control Studies , Cognitive Dysfunction/complications , Female , Humans , Male , Middle Aged , Neuroimaging/methods , Predictive Value of Tests
13.
Neuroradiol J ; 27(4): 445-51, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25196618

ABSTRACT

Small blood vessel injury is a feature of post irradiation brain. Susceptibility weighted imaging (SWI) is a technique that exploits the magnetic properties of tissues, such as blood and iron content and is thus sensitive to hemorrhage as a marker of small vessel injury. Our purpose was to assess post irradiation brain findings using SWI. We evaluated 12 patients with follow-up MRI studies who underwent cranial irradiation for primary or metastatic tumors. From their clinical records, the latency interval, type of radiation, and total dose were established. The number and the distribution of "black dots" on SWI were analyzed. We also compared the findings on SWI with those seen on other MRI sequences. In all patients, black dots were clearly identified on SWI, while on conventional MRI (T2 and FLAIR) none were visible. Two patients with glial tumors received radiation with fields conforming to tumor beds, while all other patients received whole brain irradiation or craniospinal radiation. The total radiation doses ranged from 45-54 Gy. Latency interval between the time of irradiation and time of detection of the black dots was four to 60 months (mean, 31 months). In ten patients diffuse black dots were observed and in two patients these were located in the irradiated field. Black dots occurred in the cerebrum, cerebellum, and choroid plexuses. None of these dots showed enhancement. Follow-up in four patients showed that the numbers of these black dots had increased. Black dots were not present before radiation in any patient. Radiation-related black dots are an effect of cranial irradiation and may be related to small vessel damage. SWI is a sensitive technique for evaluation of these black dots.


Subject(s)
Brain Neoplasms/radiotherapy , Cerebrovascular Trauma/diagnostic imaging , Cranial Irradiation/adverse effects , Radiation Injuries/diagnostic imaging , Adolescent , Adult , Cerebrovascular Trauma/etiology , Child , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Radiation Injuries/etiology , Young Adult
14.
Front Aging Neurosci ; 5: 47, 2013.
Article in English | MEDLINE | ID: mdl-24065917

ABSTRACT

BACKGROUND: New research criteria for diagnosing Alzheimer's disease (AD) in the mild cognitive impairment stage (MCI-AD) incorporate biomarkers to assign a level of certainty to the diagnosis. Structural MRI is widely available but greatly under-utilized for assessing atrophy of structures affected in early AD, such as the hippocampus (HP), because the quantification of HP volumes (HP-v) requires special expertise, and normative values have not been established. METHODS: Elderly subjects (n =273) from the Florida ADRC were classified as having no cognitive impairment (cognitively normal, CN), amnestic mild cognitive impairment (aMCI) or AD. Volumes for the hippocampus (HP-v) were measured on structural MRI scans. A validated visual rating system for measuring medial temporal atrophy (VRS-MTA), including hippocampal, entorhinal cortex and perirhinal cortex atrophy was employed. The participants were subdivided into younger (less than or equal to 75 years of age) and older (greater than 75 years of age) subgroups. RESULTS: Volumetric and VRS-MTA measures were equivalent in predicting classification of CN vs. aMCI for older (area under the receiver operator curves [aROC]: 0.652 vs. 0.723) and younger subjects (aROC: 0.764 vs. 0.736). However, for younger AD subjects, aROC values were significantly higher for VRS-MTA measures (0.920) than for volumetric measures (0.847). Relative to HP-v, VRS-MTA score was significantly more correlated to impairment on a range of memory tests and was more associated with progression of aMCI to AD than HP-v. CONCLUSION: Structural MRI with VRS-MTA assessment can serve as a biomarker for supporting the diagnosis of MCI-AD. Age-adjusted VRS-MTA scores are at least as effective as HP-v for distinguishing aMCI and AD from CN and for predicting progression from aMCI to AD. VRS-MTA is convenient for use in the clinic as well as for clinical trials and can readily be incorporated into a standardized radiological report.

15.
Alzheimers Dement ; 9(3): 295-301, 2013 May.
Article in English | MEDLINE | ID: mdl-23178035

ABSTRACT

OBJECTIVE: To evaluate the contributions of amyloid-positive (Am+) and medial temporal atrophy-positive (MTA+) scans to the diagnostic classification of prodromal and probable Alzheimer's disease (AD). METHODS: (18)F-flutemetamol-labeled amyloid positron emission tomography (PET) and magnetic resonance imaging (MRI) were used to classify 10 young normal, 15 elderly normal, 20 amnestic mild cognitive impairment (aMCI), and 27 AD subjects. MTA+ status was determined using a cut point derived from a previous study, and Am+ status was determined using a conservative and liberal cut point. RESULTS: The rates of MRI scans with positive results among young normal, elderly normal, aMCI, and AD subjects were 0%, 20%, 75%, and 82%, respectively. Using conservative cut points, the rates of Am+ scans for these same groups of subjects were 0%, 7%, 50%, and 93%, respectively, with the aMCI group showing the largest discrepancy between Am+ and MTA+ scans. Among aMCI cases, 80% of Am+ subjects were also MTA+, and 70% of amyloid-negative (Am-) subjects were MTA+. The combination of amyloid PET and MTA data was additive, with an overall correct classification rate for aMCI of 86%, when a liberal cut point (standard uptake value ratio = 1.4) was used for amyloid positivity. INTERPRETATION: (18)F-flutemetamol PET and structural MRI provided additive information in the diagnostic classification of aMCI subjects, suggesting an amyloid-independent neurodegenerative component among aMCI subjects in this sample.


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Magnetic Resonance Imaging/methods , Positron-Emission Tomography/methods , Adult , Aged , Aged, 80 and over , Alzheimer Disease/classification , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/pathology , Amyloid/metabolism , Aniline Compounds , Benzothiazoles , Cognitive Dysfunction/classification , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/pathology , Female , Humans , Logistic Models , Male , Middle Aged , Neocortex/diagnostic imaging , Neocortex/metabolism , Neocortex/pathology , Neuropsychological Tests , Severity of Illness Index
16.
Alzheimers Dement ; 8(3): 172-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22546351

ABSTRACT

BACKGROUND/AIMS: To investigate the clinical features and rates of progression of conditions that are not considered to be normal, but do not fulfill criteria for mild cognitive impairment (MCI). METHODS: We longitudinally evaluated 269 elderly subjects who did not meet formal criteria for MCI at baseline but had: (1) a clinical history suggesting MCI without neuropsychological deficits (PreMCI-Clinical); or (2) neuropsychological deficits on one or more memory measures in conjunction with a negative clinical examination (amnestic PreMCI-NP) or were normal on both neuropsychological and clinical examination. RESULTS: The rate of progression to MCI or dementia over an average of 2- to 3 years was 3.7% for no cognitive impairment subjects, whereas it was significantly greater for all PreMCI subtypes (22.0% for PreMCI-Clinical, 38.9% for amnestic PreMCI-NP subjects with two or more memory impairments). Among PreMCI subjects as a whole, lower baseline scores on object memory and category fluency tests were the best predictors of progression to MCI or dementia. Cardiovascular risk factors, Parkinsonian symptoms, and hippocampal atrophy were not associated with progression. CONCLUSION: Distinct PreMCI subtypes defined on the basis of clinical and neuropsychological evaluations were found to have distinct characteristics, but both subtypes demonstrated elevated risk for progression to MCI or dementia. Despite the lack of evidence of clinical impairment, subjects with neuropsychological deficits in two memory domains were particularly at increased risk for progression of their deficits.


Subject(s)
Cognitive Dysfunction/classification , Cognitive Dysfunction/diagnosis , Aged , Amnesia/diagnosis , Amnesia/etiology , Cardiovascular Diseases , Cognitive Dysfunction/physiopathology , Disease Progression , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Memory Disorders/diagnosis , Memory Disorders/etiology , Middle Aged , Neuropsychological Tests , Psychiatric Status Rating Scales , Retrospective Studies , Risk Factors
17.
Dement Geriatr Cogn Disord ; 31(4): 276-83, 2011.
Article in English | MEDLINE | ID: mdl-21494034

ABSTRACT

BACKGROUND: In Alzheimer's disease, neurodegenerative atrophy progresses from the entorhinal cortex (ERC) to the hippocampus (HP), limbic system and neocortex. The significance of very mild atrophy of the ERC and HP on MRI scans among elderly subjects is unknown. METHODS: A validated visual rating system on coronal MRI scans was used to identify no atrophy of the HP or ERC (HP(0); ERC(0)), or minimal atrophy of the HP or ERC (HP(ma); ERC(ma)), among 414 participants. Subjects fell into the following groups: (1) ERC(0)/HP(0), (2) ERC(ma)/HP(0), (3) ERC(0)/HP(ma), and (4) ERC(ma)/HP(ma). HP volume was independently measured using volumetric methods. RESULTS: In comparison to ERC(0)/HP(0) subjects, those with ERC(0)/HP(ma) had impairment on 1 memory test, ERC(ma)/HP(0) subjects had impairment on 2 memory tests and the Mini Mental State Examination (MMSE), while ERC(ma)/HP(ma) subjects had impairment on 3 memory tests, the MMSE and Clinical Dementia Rating. Progression rates of cognitive and functional impairment were significantly greater among subjects with ERC(ma). CONCLUSION: Minimal atrophy of the ERC results in greater impairment than minimal atrophy of the HP, and the combination is additive when measured by cognitive and functional tests. Rates of progression to greater impairment were higher among ERC(ma) subjects.


Subject(s)
Alzheimer Disease/pathology , Cognition Disorders/pathology , Entorhinal Cortex/pathology , Hippocampus/pathology , Magnetic Resonance Imaging , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Apolipoproteins E/genetics , Atrophy , Cognition Disorders/genetics , Disease Progression , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Severity of Illness Index
18.
Int Psychogeriatr ; 21(1): 78-85, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18814807

ABSTRACT

BACKGROUND: Psychotic symptoms in Alzheimer disease (AD + P) identify a heritable phenotype associated with greater cognitive impairment. Knowing when the cognitive course of AD + P subjects diverges from that of subjects without psychosis would enhance understanding of how genetic variation results in AD + P and its associated cognitive burden. This study seeks to determine whether the degree of cognitive impairment and cognitive decline in early AD predicts subsequent AD + P onset. METHODS: 361 subjects with possible or probable AD or mild cognitive impairment (MCI) without psychosis were evaluated every 6 months until psychosis onset. RESULTS: Severity of cognitive dysfunction was a strong predictor of AD + P up to two years prior to psychosis onset. Cognition did not decline more rapidly prior to onset of AD + P. CONCLUSIONS: Individuals who will develop AD + P already demonstrate excess cognitive impairment during the mild stages of disease. Genetic variation and brain pathophysiology may lead to a cognitive risk phenotype which is present prior to dementia onset.


Subject(s)
Alzheimer Disease/diagnosis , Cognition Disorders/diagnosis , Psychotic Disorders/diagnosis , Aged , Aged, 80 and over , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Cognition Disorders/epidemiology , Cognition Disorders/genetics , Comorbidity , Cross-Sectional Studies , Disability Evaluation , Disease Progression , Female , Follow-Up Studies , Genetic Predisposition to Disease/genetics , Humans , Male , Mental Status Schedule/statistics & numerical data , Neuropsychological Tests/statistics & numerical data , Pennsylvania , Phenotype , Psychometrics , Psychotic Disorders/epidemiology , Psychotic Disorders/genetics , Risk Factors
19.
J Child Neurol ; 18(11): 741-7, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14696900

ABSTRACT

The objective of this study was to investigate the incidence of acute flaccid paralysis in the pediatric population of Honduras over an 11-year period, determine what percentage of acute flaccid paralysis was Guillain-Barré syndrome, and identify the epidemiologic features of Guillain-Barré syndrome. There were 546 childhood cases of acute flaccid paralysis seen between January 1989 and December 1999 at the Hospital Escuela Materno-Infantil in Tegucigalpa, Honduras. Of these cases with acute flaccid paralysis, 394 (72.2%) were diagnosed with Guillain-Barré syndrome. Our incidence of Guillain-Barré syndrome in the Honduran pediatric population (1.37/100,000 per year) is higher than that shown in other studies. There was a significantly higher incidence of Guillain-Barré syndrome in younger children (ages 1-4 years), a significant preponderance of cases from rural areas, and a mild predominance in boys but a typical clinical presentation. The Honduran pediatric Guillain-Barré syndrome population had an increased mortality rate. Guillain-Barré syndrome has become the leading cause of childhood paralysis in Honduras. A better understanding of the population at highest risk and opportunities for earlier intervention with more effective therapeutic modalities may permit reducing the mortality among Honduran children who develop Guillain-Barré syndrome.


Subject(s)
Guillain-Barre Syndrome/complications , Guillain-Barre Syndrome/epidemiology , Muscle Hypotonia/epidemiology , Muscle Hypotonia/etiology , Paralysis/epidemiology , Paralysis/etiology , Acute Disease , Adolescent , Age Distribution , Child , Child, Preschool , Female , Honduras/epidemiology , Humans , Incidence , Infant , Male , Sex Distribution , Time Factors
20.
Epilepsy Behav ; 4(3): 348-51, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12791340

ABSTRACT

The characteristic features of Kluver-Bucy syndrome include hypersexuality, hyperorality, placidity, hypermetamorphosis, visual agnosia, changes in dietary habits, and memory impairment. Human cases have been reported with herpes simplex encephalitis, head injury, Pick's disease, transtentorial herniation, adrenoleukodystrophy, and Reye's syndrome, all involving bilateral temporal lobe pathology. We present the case of a patient with no evidence of a structural lesion in the temporal lobes and behavioral changes consistent with Kluver-Bucy syndrome following complex partial status epilepticus.


Subject(s)
Epilepsy, Complex Partial/complications , Kluver-Bucy Syndrome/etiology , Adult , Anticonvulsants/therapeutic use , Carbamazepine/therapeutic use , Electroencephalography , Epilepsy, Complex Partial/diagnosis , Epilepsy, Complex Partial/drug therapy , Functional Laterality/physiology , Hemodynamics/physiology , Humans , Male , Temporal Lobe/blood supply , Time Factors , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...